Methods for isolating crystalline Form I of 5-azacytidine
Details for Australian Patent Application No. 2004222274 (hide)
International Classifications
Event Publications
22 September 2005 PCT application entered the National Phase
PCT publication WO2004/082822 Priority application(s): WO2004/082822
7 October 2010 Amendment Made
The nature of the amendment is: Amend co-inventor name from Silvey, Gary L. to Selvey, Lee Alani
4 November 2010 Assignment before Grant
Pharmion Corporation; Ash Stevens Inc The application has been assigned to Celgene International SARL
4 November 2010 Application Accepted
Published as AU-B-2004222274
3 March 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004222279-Retinoid replacements and opsin agonists and methods for the use thereof
2004222272-Facially amphiphilic polymers and oligomers and uses thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser